title: Apolipoprotein CI levels are associated with atherosclerosis in men with the metabolic syndrome and systemic inflammation.
authors.forename: R L M
authors.initials: RL
authors.lastname: van der Ham
authors.forename: R Alizadeh
authors.initials: RA
authors.lastname: Dehnavi
authors.forename: G A
authors.initials: GA
authors.lastname: van den Berg
authors.forename: H
authors.initials: H
authors.lastname: Putter
authors.forename: A
authors.initials: A
authors.lastname: de Roos
authors.forename: J F P
authors.initials: JF
authors.lastname: Berbée
authors.forename: J A
authors.initials: JA
authors.lastname: Romijn
authors.forename: P C N
authors.initials: PC
authors.lastname: Rensen
authors.forename: J T
authors.initials: JT
authors.lastname: Tamsma
mesh_terms: D000368:Aged; D053302:Apolipoprotein C-I / Q000097:blood*; D050197:Atherosclerosis / Q000097:blood* / Q000150:complications; D002097:C-Reactive Protein / Q000096:biosynthesis; D050171:Dyslipidemias / Q000097:blood / Q000150:complications; D004730:Endothelium, Vascular / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000150:complications; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000150:complications; D008875:Middle Aged; D014280:Triglycerides / Q000378:metabolism
chemical_list: D053302:Apolipoprotein C-I; D014280:Triglycerides; D002097:C-Reactive Protein